Mini Curriculum Vitae

TERREUX Raphael
Raphael TERREUX

Equipe : Groupe EcMo
Courriel : raphael.terreux@ibcp.fr
Téléphone : +33(0)4-37-65-29-43
Statut : Professeur

52 publications au total. Seules les 5 dernières années sont affichées

2021
52.  Discovery of a Novel Non-Narcotic Analgesic Derived from the CL-20 Explosive: Synthesis, Pharmacology, and Target Identification of Thiowurtzine, a Potent Inhibitor of the Opioid Receptors and the Ion Channels. 
Aguero S, Megy S, Eremina Vv, Kalashnikov Ai, Krylova Sg, Kulagina Da, Lopatina Ka, Fournier M, Povetyeva Tn, Vorozhtsov Ab, Sysolyatin Sv, Zhdanov Vv, Terreux R
(2021) Acs Omega 6 :15400-15411  Icon PUBMED

51.  Latent TGF-β Activation Is a Hallmark of the Tenascin Family. 
Aubert A, Mercier-gouy P, Aguero S, Berthier L, Liot S, Prigent L, Alcaraz Lb, Verrier B, Terreux R, Moali C, Lambert E, Valcourt U
(2021) Front Immunol 12 :613438-613438  Icon PUBMED

50.  Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms. 
Da Costa D, Exbrayat-héritier C, Rambaud B, Megy S, Terreux R, Verrier B, Primard C
(2021) J Nanobiotechnology 19 :12-12  Icon PUBMED

49.  Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2. 
Guragossian N, Belhani B, Moreno A, Nunes Mt, Gonzalez-lobato L, Marminon C, Berthier L, Rocio Andrade Pires Ad, Özvegy-laczka C, Sarkadi B, Terreux R, Bouaziz Z, Berredjem M, Jose J, Di Pietro A, Falson P, Le Borgne M
(2021) Eur J Med Chem 211 :113017-113017  Icon PUBMED

2020
48.  Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam1CSK4 and Pam3CSK4. 
Megy S, Aguero S, Da Costa D, Lamrayah M, Berthet M, Primard C, Verrier B, Terreux R
(2020) Nanomaterials (basel) 10 :  Icon PUBMED

2019
47.  Molecular modelling of TLR agonist Pam(3)CSK(4) entrapment in PLA nanoparticles as a tool to explain loading efficiency and functionality. 
Lamrayah M, Charriaud F, Hu S, Megy S, Terreux R, Verrier B
(2019) Int J Pharm 568 :118569-118569  Icon PUBMED

2018
46.  In Silico, in Vitro, and in Vivo Evaluation of New Candidates for ?-Synuclein PET Imaging. 
Verdurand M, Levigoureux E, Zeinyeh W, Berthier L, Mendjel-herda M, Cadarossanesaib F, Bouillot C, Iecker T, Terreux R, Lancelot S, Chauveau F, Billard T, Zimmer L
(2018) Mol Pharm 15 :3153-3166  Icon PUBMED

2017
45.  Ames test prediction on High Energy Molecules by On-The-Fly QSAR (OTF-QSAR) 
Alliod C, Chemelle Ja, Jacob G, Terreux R
(2017) Propellants, Explosives, Pyrotechnics 42 :24-35

44.  Destabilization of the TWIST1/E12 complex dimerization following the R154P point-mutation of TWIST1: an in silico approach. 
Bouard C, Terreux R, Tissier A, Jacqueroud L, Vigneron A, Ansieau S, Puisieux A, Payen L
(2017) Bmc Struct Biol 17 :6-6  Icon PUBMED